Publications

Institut für Klinische Molekularbiologie der Christian-Albrechts-Universität zu Kiel

2020

Rapid response of stage IV colorectal cancer with APC/TP53/KRAS mutations to FOLFIRI and Bevacizumab combination chemotherapy: a case report of use of liquid biopsy.
PubMed (PMID: 31900123) | 2020 | BMC medical genetics
Carotenoids are used as regulators for membrane fluidity by Staphylococcus xylosus.
PubMed (PMID: 31941915) | 2020 | Scientific Reports
Adrenergic Signaling in Muscularis Macrophages Limits Infection-Induced Neuronal Loss.
PubMed (PMID: 31923400) | 2020 | Cell
Autophagy of Intestinal Epithelial Cells Inhibits Colorectal Carcinogenesis Induced by Colibactin-producing Escherichia coli in ApcMin/+ Mice.
PubMed (PMID: 31917256) | 2020 | Gastroenterology (New York, N.Y. 1943)
Increasing prevalence of a fluoroquinolone resistance mutation amongst Campylobacter jejuni isolates from four human infectious intestinal disease studies in the United Kingdom.
PubMed (PMID: 31999701) | 2020 | PloS one
Stage IV Colorectal Cancer Patients with High Risk Mutation Profiles Survived 16 Months Longer with Individualized Therapies.
PubMed (PMID: 32046290) | 2020 | Cancers